Raymond James Trust’s Celgene Corp CELG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-27,763
| Closed | -$2.76M | – | 994 |
|
|
2019
Q3 | $2.76M | Sell |
27,763
-1,005
| -3% | -$95.5K | 0.14% | 144 |
|
|
2019
Q2 | $2.66M | Sell |
28,768
-594
| -2% | -$56.4K | 0.15% | 144 |
|
|
2019
Q1 | $2.77M | Sell |
29,362
-5,094
| -15% | -$446K | 0.16% | 135 |
|
|
2018
Q4 | $2.21M | Sell |
34,456
-1,619
| -4% | -$120K | 0.14% | 151 |
|
|
2018
Q3 | $3.23M | Buy |
36,075
+2,853
| +9% | +$252K | 0.18% | 123 |
|
|
2018
Q2 | $2.64M | Sell |
33,222
-1,092
| -3% | -$90.7K | 0.16% | 138 |
|
|
2018
Q1 | $3.06M | Buy |
34,314
+437
| +1% | +$42K | 0.21% | 110 |
|
|
2017
Q4 | $3.54M | Buy |
33,877
+1,439
| +4% | +$162K | 0.24% | 99 |
|
|
2017
Q3 | $4.73M | Buy |
32,438
+2,306
| +8% | +$314K | 0.34% | 77 |
|
|
2017
Q2 | $3.91M | Buy |
30,132
+5,329
| +21% | +$653K | 0.29% | 91 |
|
|
2017
Q1 | $3.09M | Sell |
24,803
-1,795
| -7% | -$215K | 0.23% | 104 |
|
|
2016
Q4 | $3.08M | Buy |
26,598
+8,814
| +50% | +$982K | 0.25% | 100 |
|
|
2016
Q3 | $1.86M | Buy |
17,784
+1,383
| +8% | +$150K | 0.16% | 138 |
|
|
2016
Q2 | $1.62M | Buy |
16,401
+338
| +2% | +$35K | 0.14% | 152 |
|
|
2016
Q1 | $1.61M | Sell |
16,063
-2,683
| -14% | -$276K | 0.15% | 143 |
|
|
2015
Q4 | $2.25M | Buy |
18,746
+3,660
| +24% | +$423K | 0.21% | 113 |
|
|
2015
Q3 | $1.63M | Buy |
15,086
+153
| +1% | +$19K | 0.18% | 124 |
|
|
2015
Q2 | $1.73M | Sell |
14,933
-1,435
| -9% | -$164K | 0.18% | 129 |
|
|
2015
Q1 | $1.89M | Sell |
16,368
-1,085
| -6% | -$130K | 0.2% | 119 |
|
|
2014
Q4 | $1.95M | Sell |
17,453
-725
| -4% | -$76.5K | 0.21% | 113 |
|
|
2014
Q3 | $1.72M | Buy |
18,178
+8,486
| +88% | +$766K | 0.2% | 115 |
|
|
2014
Q2 | $832K | Sell |
9,692
-9,238
| -49% | -$703K | 0.1% | 211 |
|
|
2014
Q1 | $1.32M | Sell |
18,930
-458
| -2% | -$36.3K | 0.16% | 132 |
|
|
2013
Q4 | $1.64M | Buy |
19,388
+294
| +2% | +$23.3K | 0.22% | 111 |
|
|
2013
Q3 | $1.47M | Buy |
19,094
+2,910
| +18% | +$204K | 0.23% | 109 |
|
|
2013
Q2 | $946K | Buy |
+16,184
| New | +$974K | 0.15% | 145 |
|
Other funds holding CELG
FP
HCM
PCMC
WCG
Raymond James Trust's CELG Position: Q4 2019 in Review
Raymond James Trust sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 27,763 shares — an estimated $2.76M sold.
Raymond James Trust first reported a position in CELG in Q2 2013 and held it in 26 quarters. The position peaked at $4.73M in Q3 2017. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.
- Raymond James Trust reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
- Raymond James Trust sold 27,763 Celgene Corp shares in Q4 2019, an estimated $2.76M.
- Raymond James Trust first reported a position in Celgene Corp in Q2 2013 and held it in 26 quarters.
- Raymond James Trust's Celgene Corp position peaked at $4.73M in Q3 2017.
- 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.
Based on Raymond James Trust's 13F filing for Q4 2019, filed 14 Jan 2020.